MAKENZA 40MG CAPS

Product Description

• Active Ingredient: The primary active ingredient is Enzalutamide. Some sources indicate it might contain Everolimus as an active ingredient, so the exact composition depends on the specific formulation and manufacturer.
• Mechanism of Action: It acts as an androgen receptor inhibitor, which means it blocks the effects of male hormones like testosterone that prostate cancer cells need to grow. This action helps to slow down the progression of the cancer.
• Primary Use: It is primarily prescribed for the treatment of prostate cancer that is castration-resistant (cancer that has stopped responding to other treatments that lower testosterone levels). It can be used for both metastatic (spread to other parts of the body) and non-metastatic forms of this cancer.

• Prescription Drug: Makenza 40 is a prescription medicine and should be used only under the strict guidance and advice of a medical professional.
• Potential Side Effects: Common side effects can vary depending on the active ingredient, but may include headache, dizziness, fatigue, and high blood pressure. Enzalutamide, specifically, can rarely increase the risk of seizures.
• Safety: Do not engage in self-medication. Consult with a doctor or pharmacist before taking this or any other medication to ensure it is safe and appropriate for your condition.